Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1382 of 6351
-
New app aims to help young adults kick the vaping habit
Symptom relief Recruiting nowThis clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the…
Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New strategy training aims to outsmart Parkinson's brain fog
Symptom relief Recruiting nowMild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem. Unfortunat…
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
AI app could replace physiotherapist for knee pain relief
Symptom relief Not yet recruitingThe goal of the study is to confirm the idea of AI-powered Technological Surrogate Physiotherapist (TSP), by demonstrating its effectiveness and value as a new technology-based contribution to OA healthcare. Participants will be randomized to one of two groups: (1) the convention…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could a simple steroid injection keep your airway open longer?
Disease control Recruiting nowThis study will examine the ability of steroid injections into the site of stenosis following surgical dilation to delay the need for repeated surgical dilations.
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for kids with tough leukemia: experimental drug enters human testing
Disease control Recruiting nowAcute myeloid leukemia (AML) is an aggressive blood cancer, withwith few options for participants who relapse after treatment or who don't respond to treatment. This study will assess the adverse events and how pivekimab sunirine moves through the body in pediatric participants w…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Could blood pressure pills boost stomach cancer treatment?
Disease control Not yet recruitingStudy Population:Patients with locally advanced gastric cancer complicated by hypertension, who are scheduled to undergo laparoscopic gastric cancer resection after receiving preoperative immunotherapy. Primary Objective: To investigate the impact of combined beta-blocker use on…
Phase 2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a simple arm cuff replace bloodletting for high altitude disease?
Disease control Not yet recruitingThis study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The participants are adult patients with high-altitude polycythemia who have been long-term residents (for \>6 months) in regions at an altitude of ≥2500 meters. Participants are…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug SKB571 aims to shrink GI tumors in early trial
Disease control Recruiting nowThis is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability and preliminary anti-tumor activity of SKB571 in participants with gastrointestinal tumors.
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could heart failure patients skip some drugs after surgery? new trial investigates
Disease control Recruiting nowIn patients with heart failure due to a reversible underlying cause-such as valvular heart disease or coronary artery disease-surgical or procedural correction of the underlying lesion (valve repair/replacement, TAVI, PCI, or CABG) frequently leads to spontaneous recovery of card…
Phase 4 • Sponsor: Kyungsub Song • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Ultrasound may spare breast cancer patients unnecessary surgery
Diagnosis Not yet recruitingThis study aims to evaluate whether longitudinal multimodal ultrasound can accurately predict axillary pathological response in breast cancer patients who receive neoadjuvant chemotherapy. In this study, patients with biopsy-proven metastatic axillary lymph nodes will have a meta…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New study tests Clot-Busting procedure for severe leg clots
Disease control Recruiting now* Iliofemoral DVTs (IF DVTs) are vascular disorders associated with high morbidity and mortality, which can be complicated by long-term post-thrombotic syndrome (PTS). * Pharmaco mechanical thrombolysis (PMT) is an innovative endovascular technique involving in situ fibrinolysis …
Phase 4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy for bile duct cancer enters safety trial
Disease control Recruiting nowThe goal of this clinical trial is to provide evidence for the general tolerability of radiofrequency ablation (bRFA) in patients with unresectable bile duct cancer undergoing systemic palliative treatment consisting of systemic anti-tumor therapy with or without immune-checkpoin…
Phase 2 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill aims to plug protein leak in kidney patients
Disease control Recruiting nowThis is a Phase 1b/2, open-label, multi-center study evaluating the therapeutic potential and safety of the investigational drug EVER001 in adults with FSGS, MCD, or IgAN. EVER001 acts on multiple immune pathways without directly affecting T cells or depleting B cells (both are l…
Phase 2 • Sponsor: Everest Medicines (China) Co.,Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New injection could unpinch nerves in diabetic legs
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a single session of ultrasound-guided nerve hydrodissection can relieve symptoms of diabetic lower limb entrapment neuropathy, a condition caused by compressed nerves in the leg that leads to numbness, pain, or muscle weakness in peo…
Sponsor: Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Lung cancer surgery showdown: less invasive sampling may match full dissection
Disease control Not yet recruitingThe SCIENCE trial is a multicenter, open-label, randomized, parallel, noninferiority investigator-initiated trial (IIT). This study aims to evaluate the prognostic differences between selective mediastinal lymph node sampling and systematic mediastinal lymph node dissection in pa…
Phase 3 • Sponsor: Wen-zhao ZHONG • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a zap to the ear boost memory in diabetes patients?
Disease control Not yet recruitingThis study is a 24-week, single-center, randomized, double-blind, sham-controlled, parallel-group clinical trial. A total of 38 patients with type 2 diabetes and mild cognitive impairment were enrolled and randomly assigned in a 1:1 ratio to either the treatment group (receiving …
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Heart attack patients may benefit from Clot-Busting drug before delayed procedure
Disease control Not yet recruitingThis study aims at evaluating of the effectiveness of in-hospital thrombolysis for ST-segment elevation myocardial infarction in PCI centers under conditions of predicted in-hospital delay (\>60 min after admission in PCI-center) of PCI. Following randomisation a strategy of earl…
Phase 4 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a new gel make eye injections less painful?
Symptom relief CompletedProspective comparative clinical study. One hundred eyes of 50 patients were included. All patients received bilateral same-day intravitreal injections, with Iheezo administered to only one randomly selected eye and standard topical anesthesia administered to the contralateral c…
Phase 4 • Sponsor: Retina Consultants of Delmarva • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can a structured handoff improve care for rare hormone disorders?
Disease control Recruiting nowThis study will evaluate the transition from pediatric to adult care in patients with pediatric-onset rare endocrine disorders. The study includes three components: a review of medical records to assess previous transition outcomes, a survey of adult patients about transition exp…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Yoga on the clock: a new hope against healthcare burnout?
Symptom relief OngoingThis study aims to evaluate changes in burnout, perceived stress, coping strategies, anxiety, depression, and psychological well-being among healthcare workers participating in a workplace yoga program. Healthcare professionals are frequently exposed to high emotional demands, w…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC